JKC363

This potent and selective MC4 receptor antagonist (IC50 = 0.5 nM at MC4 vs. 44.9 nM at MC3) blocks α-MSH effects. It is a valuable research tool for studying energy homeostasis and nociception, as it suppresses TRH release, attenuates food intake, and reduces formalin-induced pain in vivo.